Avidity Biosciences (NASDAQ:RNA) Earns Sector Outperform Rating from Analysts at Scotiabank
Scotiabank began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report issued on Friday morning, ...
Fintel on MSN2d
Scotiabank Initiates Coverage of Avidity Biosciences (RNA) with Sector Outperform Recommendation
Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Sector ...
Avidity Biosciences initiated with an Outperform at Scotiabank
Scotiabank analyst Louise Chen initiated coverage of Avidity Biosciences (RNA) with an Outperform rating and $70 price target The firm sees a ...
Avidity Biosciences (NASDAQ:RNA) Shares Gap Down After Analyst Downgrade
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down before the market opened on Monday after Barclays lowered their price target on the stock from $63.00 to $57.00. The ...